AIDS in Intensive Care Unit Patients: Epidemiology and OutcomesAlessandro Kenji YassueM1, Camila Artuzi Oliveira1, Claudia Santos Oliveira1, Luana Tossolini Goulart1, Karina H Oikawa2, Amaury C Jorge2, Carla Sakuma Oliveira2 and Péricles AD Duarte2
- Corresponding Author:
- Pericles AD Duarte
General ICU–Hospital Universitário do Oeste do Paraná
Av. Tancredo Neves, 3224 - Santa Cruz
Cascavel - PR, 85806-470, Brazil
E-mail: [email protected]; [email protected]
Received date: April 27, 2017; Accepted date: May 12, 2017; Published date: May 19, 2017
Citation: Yassue AK, Oliveira CA, Oliveira CS, Goulart LT, Oikawa KH, et al. (2017) AIDS in Intensive Care Unit Patients: Epidemiology and Outcomes. J AIDS Clin Res 8:691. doi:10.4172/2155-6113.1000691
Copyright: © 2017 Yassue AK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: Admission rates to intensive care unit (ICU) remains high in AIDS patients, although data in lowincome countries are scarce. The aim of this study was to evaluate the epidemiology, morbidity and mortality risk factors of HIV/AIDS patients admitted to the ICU of a university hospital in southern Brazil. Methods: Retrospective cohort study with all patients aged >18 years in the ICU from 2004 to 2014 with a diagnosis of HIV/AIDS (previous or newly diagnosed). Results: 1.7% of ICU patients had HIV/AIDS; of these, 67.1% were male, with an average of 40 years. 91.8% of hospitalizations were due to clinical causes, and most patients (83.6%) had no comorbidities. Mean APACHE 25.1, 95.1% required invasive mechanical ventilation (MV), ICU stay 13.9 days, mortality 51.4%. Among AIDS patients, incidence of complications was high: 41.7% acute respiratory distress syndrome (ARDS), 45.8% acute renal failure (ARF), 37.5% pneumonia. Approximately 1/3 had diagnosis during hospitalization and 27.5% were on antiretroviral therapy. Mortality has progressively reduced over the years. Conclusion: The prevalence of HIV/AIDS was 1.7%. This group had a high incidence of complications, which were related to higher mortality. The mortality of this group has decreased in recent years in this population.